(Q33409403)
Statements
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus (English)
Annegret Kuhn
Anna Wozniacka
Surasak Nilganuwong
Anders A Bengtsson
Dick E de Vries
Bart van Hartingsveldt
Donald W Robinson
Robert Gordon
Ronald F van Vollenhoven